Delivery Order SPE2DB22D3501-SPE2DB25FTJ80

Award Date 11/1/24
Potential Completion Date 11/4/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,007.82 firm fixed-price delivery order is for the supply of "COMBIPATCH 0.05-0.14 MG PTCH 8S", a pharmaceutical product, with a period of performance through March 26, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $1,501.26 firm-fixed-price delivery order is for the supply of COMBIPATCH 0.05-0.14 MG PTCH 8S, a medical product. The contract has a completion date of July 29, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the...
The federal contract award is for the delivery of COMBIPATCH 0.05-0.25 MG PTCH 8S medical supplies to the Defense Logistics Agency (DLA). The $1,974.02 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 30, 2024, with an ultimate completion date of October 31, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which provides...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,050.51 firm fixed-price delivery order is for the supply of COMBIPATCH 0.05-0.14 MG PTCH 8S medical products. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COMBIPATCH 0.05-0.14 MG PTCH 8S, a pharmaceutical product, with an ultimate completion date of May 30, 2025 and a ceiling value of $1,494.22. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,056.32 firm fixed-price delivery order is for the supply of COMBIPATCH 0.05-0.14 MG PTCH 8S, a medical product, with a completion date of June 29, 2023. The contract is not designated as a set-aside and is awarded under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for $1,466.98 and was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the medical product "COMBIPATCH 0.05-0.14 MG PTCH 8S" and has a completion date of December 23, 2024. The contract is a Firm Fixed Price arrangement and was not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of COMBIPATCH 0.05-0.14 MG PTCH 8S medical patches. The contract has a firm fixed price of $2,975.82 and a completion date of September 11, 2024. Amerisourcebergen, a major pharmaceutical distributor, was awarded this delivery order under an existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,046.28, is for the delivery of COMBIPATCH 0.05-0.14 MG PTCH 8S, a type of medical patch. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of June 9, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,195.28 firm fixed-price delivery order is for the supply of COMBIPATCH 0.05-0.14 MG PTCH 8S, a medical product, with a performance period ending on March 16, 2022. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FTJ80
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery order of COMBIPATCH 0.05-0.14 MG PTCH 8S medical patches. The $1,101.40 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) and has a completion date of November 4, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have any set-aside designations, indicating open competition. This award aligns with the DLA's role in supplying critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other supplies, to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 1/31/25, 9:02 AM